IL100337A - Methylenebisphosphonic acid derivatives their preparation and pharmaceutical compositions containing them - Google Patents

Methylenebisphosphonic acid derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL100337A
IL100337A IL10033791A IL10033791A IL100337A IL 100337 A IL100337 A IL 100337A IL 10033791 A IL10033791 A IL 10033791A IL 10033791 A IL10033791 A IL 10033791A IL 100337 A IL100337 A IL 100337A
Authority
IL
Israel
Prior art keywords
opt
preparation
pharmaceutical compositions
compositions containing
acid derivatives
Prior art date
Application number
IL10033791A
Other languages
English (en)
Other versions
IL100337A0 (en
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of IL100337A0 publication Critical patent/IL100337A0/xx
Publication of IL100337A publication Critical patent/IL100337A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025—Esters of poly(thio)phosphonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Luminescent Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
IL10033791A 1990-12-20 1991-12-11 Methylenebisphosphonic acid derivatives their preparation and pharmaceutical compositions containing them IL100337A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI906295A FI89366C (fi) 1990-12-20 1990-12-20 Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat

Publications (2)

Publication Number Publication Date
IL100337A0 IL100337A0 (en) 1992-09-06
IL100337A true IL100337A (en) 2000-12-06

Family

ID=8531620

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10033791A IL100337A (en) 1990-12-20 1991-12-11 Methylenebisphosphonic acid derivatives their preparation and pharmaceutical compositions containing them

Country Status (25)

Country Link
US (1) US5393748A (de)
EP (1) EP0563107B1 (de)
JP (1) JP3224817B2 (de)
KR (1) KR100220157B1 (de)
CN (1) CN1030253C (de)
AT (1) ATE192452T1 (de)
AU (1) AU664541B2 (de)
CA (1) CA2098735C (de)
CZ (1) CZ288084B6 (de)
DE (1) DE69132164T2 (de)
DK (1) DK0563107T3 (de)
EE (1) EE02949B1 (de)
ES (1) ES2147726T3 (de)
FI (1) FI89366C (de)
HU (1) HUT64549A (de)
IE (1) IE914389A1 (de)
IL (1) IL100337A (de)
NO (1) NO302074B1 (de)
NZ (1) NZ241040A (de)
PL (1) PL169796B1 (de)
RU (1) RU2086556C1 (de)
SK (1) SK279601B6 (de)
TW (1) TW201752B (de)
WO (1) WO1992011269A1 (de)
ZA (1) ZA9110008B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI89365C (fi) * 1990-12-20 1993-09-27 Leiras Oy Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat
US5157027A (en) * 1991-05-13 1992-10-20 E. R. Squibb & Sons, Inc. Bisphosphonate squalene synthetase inhibitors and method
CZ282760B6 (cs) * 1991-11-22 1997-09-17 Procter And Gamble Pharmaceuticals, Inc. Risedronátové prostředky se zpožděným uvolňováním
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
US6444656B1 (en) 1992-12-23 2002-09-03 Biochem Pharma, Inc. Antiviral phosphonate nucleotides
US6005107A (en) * 1992-12-23 1999-12-21 Biochem Pharma, Inc. Antiviral compounds
GB9226879D0 (en) * 1992-12-23 1993-02-17 Iaf Biochem Int Anti-viral compounds
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
DE4435496A1 (de) * 1994-10-04 1996-04-11 Hoechst Ag Imidobisphosphorsäuren, Verfahren zu ihrer Herstellung und Verwendung derselben
FI104901B (fi) * 1997-10-20 2000-04-28 Leiras Oy Uudet metyleenibisfosfonihappojohdannaiset
CZ297264B6 (cs) 1998-09-09 2006-10-11 Metabasis Therapeutics, Inc. Nové heteroaromatické inhibitory fruktóza-1,6-bisfosfatázy
SE9903345D0 (sv) 1999-09-17 1999-09-17 Astra Pharma Prod Novel process
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
EP1328277B1 (de) * 2000-10-27 2007-02-14 Schering Aktiengesellschaft Bisphosphonsäurederivate zur stärkung von kortikalknochen
ES2336312T3 (es) * 2001-07-16 2010-04-12 Universite Paris 13 Procedimiento de preparacion de derivados de bisfosfonatos.
US20030036537A1 (en) * 2001-07-16 2003-02-20 Marc Lecouvey Bisphosphonate derivatives, their preparations and uses
FR2837490B1 (fr) * 2002-03-21 2009-04-17 Univ Paris 13 Nouveaux derives de bisphosphonates, leurs preparations et utilisations
US7208481B2 (en) * 2002-02-19 2007-04-24 Ilex Products, Inc. Aminodiphosphonate apolipoprotein E modulators
RU2220588C1 (ru) * 2002-08-06 2004-01-10 Научно-производственный центр "БИОЭКОСАН" Состав для получения кормовой добавки и способ ее получения
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
CN102124016A (zh) * 2008-07-11 2011-07-13 斯索恩有限公司 制备1-羟基亚烷基-1，1-双膦酸的方法
CA2778015C (en) * 2009-10-26 2016-08-02 Warner Chilcott Company, Llc Bisphosphonate compounds for treating bone metabolism disorders
TWI730039B (zh) * 2016-01-29 2021-06-11 日商富士藥品股份有限公司 新穎雙膦酸化合物
CN108218918A (zh) * 2018-03-01 2018-06-29 四川大学 芳基偕二磷酸衍生物制备方法和用途
CN121471259B (zh) * 2026-01-08 2026-07-03 浙江工业大学 一种双膦酸及其盐类化合物、其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303139A (en) * 1962-01-27 1967-02-07 Henkel & Cie Gmbh Aminophosphonic acids and their derivatives as complex formers for metal ions
DE1617118C3 (de) * 1966-08-26 1975-04-03 Henkel & Cie Gmbh, 4000 Duesseldorf Verfahren zur Reinigung von etikettierten starren Gegenständen
US3957858A (en) * 1970-04-13 1976-05-18 Monsanto Company Substituted ethane diphosphonic acids and salts and esters thereof
US3962318A (en) * 1970-04-13 1976-06-08 Monsanto Company Substituted ethane diphosphonic acids and salts and esters thereof
US4447256A (en) * 1977-07-20 1984-05-08 Nissan Chemical Industries, Ltd. N-(Unsubstituted or substituted pyridyl)aminomethylene-diphosphonic acids, herbicidal compositions containing same, their use for herbicides, and process for preparing same
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
GB8530603D0 (en) * 1985-12-12 1986-01-22 Leo Pharm Prod Ltd Chemical compounds
HU199151B (en) * 1987-03-10 1990-01-29 Yamanouchi Pharma Co Ltd Process for producing bis-phosphonic acid derivatives
EP0356866A3 (de) * 1988-08-29 1991-03-27 E.R. SQUIBB & SONS, INC. Phosphor enthaltende Squalen-Synthetase-Inhibitoren und Verfahren

Also Published As

Publication number Publication date
AU9068291A (en) 1992-07-22
CN1062534A (zh) 1992-07-08
IE914389A1 (en) 1992-07-01
RU2086556C1 (ru) 1997-08-10
FI89366B (fi) 1993-06-15
DE69132164D1 (de) 2000-06-08
CN1030253C (zh) 1995-11-15
FI906295A0 (fi) 1990-12-20
ATE192452T1 (de) 2000-05-15
HUT64549A (en) 1994-01-28
AU664541B2 (en) 1995-11-23
ES2147726T3 (es) 2000-10-01
SK279601B6 (sk) 1999-01-11
CZ121793A3 (en) 1994-10-19
NZ241040A (en) 1994-07-26
JPH06504769A (ja) 1994-06-02
US5393748A (en) 1995-02-28
FI906295A7 (fi) 1992-06-21
NO932255D0 (no) 1993-06-18
IL100337A0 (en) 1992-09-06
HU9301781D0 (en) 1993-09-28
ZA9110008B (en) 1992-09-30
JP3224817B2 (ja) 2001-11-05
EP0563107B1 (de) 2000-05-03
CA2098735C (en) 2002-03-05
KR930703335A (ko) 1993-11-29
WO1992011269A1 (en) 1992-07-09
DE69132164T2 (de) 2001-01-11
SK63493A3 (en) 1994-09-07
TW201752B (de) 1993-03-11
CZ288084B6 (cs) 2001-04-11
PL169796B1 (pl) 1996-08-30
CA2098735A1 (en) 1992-06-21
EE02949B1 (et) 1996-12-16
DK0563107T3 (da) 2000-09-25
EP0563107A1 (de) 1993-10-06
NO932255L (no) 1993-08-20
NO302074B1 (no) 1998-01-19
FI89366C (fi) 1993-09-27
KR100220157B1 (ko) 1999-10-01

Similar Documents

Publication Publication Date Title
ZA9110008B (en) Methylenebisphosphonic acid derivatives
EE02948B1 (et) Metüleenbisfosfoonhappe derivaadid, meetod nende valmistamiseks ja farmatseutiline kompositsioon
FI105686B (fi) Menetelmä terapeuttisesti käyttökelpoisen yhdisteen ja sen fysiologisesti hyväksyttävien suolojen valmistamiseksi
KR910019630A (ko) 프라바스타틴 및 제약상 허용되는 담체로 이루어진 혈관형성수술후의 재협착 발생 방지용 제약 조성물
IL104090A (en) Phosphonosuccinic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing these compounds
IL118957A (en) 7-alkyl-(substituted alkoxy)-camptothecin derivatives their preparation and pharmaceutical compositions containing them
KR910000765A (ko) 포스핀산 유도체
ES474288A1 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo-(3,2,0)-hept-2-en-carboxilico 3 y 6-sus-tituidos
HUT49612A (en) Process for producing new 3-alkenyl-1-azabicyclo/3.2.0/ hept-2-ene-2-carboxylic acid derivatives and pharmaceutical compositions comprising same
IL124563A (en) 5-phenyl-3-(substituted oximino) pyrrolo [3, 2-h] isoquinoline-2-one derivatives pharmaceutical compositions containing them and their preparation
IL90424A (en) Cephem derivatives, processes for the preparation thereof and pharmaceutical composition containing the same
BRPI0409088A (pt) composições farmacêuticas para administração intranasal de ácido [2-(8,9-dioxo-2,6-diazabiciclo [5.2.0]non-1(7)-en-2-il)alquil]-fosfÈnico e derivados e métodos de uso dos mesmos
EP0518299A3 (en) Phosphonic acid derivatives, production and use thereof
DK0443956T3 (da) Mælkesyreacylater, deres fremstilling samt farmaceutiske præparater med indhold deraf
ES2013379A6 (es) Procedimiento para preparar 6-sulfenamido-6, sulfinamido- y 6-sulfonamido-purinas, nucleosidos de purinas y nucleotidos de purinas antitumorales.
FI941517A0 (fi) Bentsonaftyridiinin-1,8 johdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
DE3374410D1 (en) Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives
IE902273L (en) Compositions of 5-phenyl-2-furan esters amides and ketones
IL81258A0 (en) Dihydropyridinelactols,their preparation and pharmaceutical compositions containing them
FI950259A0 (fi) Uudet, asykliset, amidiiniryhmiä sisältävät difosfonihappojohdannaiset, menetelmä niiden valmistamiseksi ja näitä yhdisteitä sisältävät lääkeaineet
ES8801227A1 (es) Procedimiento para preparar derivados de benzazol
DE2963724D1 (en) Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees